author-photo

Leighann Bailey

Duke University

14

Papers

1782

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Safety and efficacy of the addition of bevacizumab to temozolomide and radiation therapy followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma multiforme.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Bevacizumab and daily temozolomide for recurrent glioblastoma.

2012 Cancer
Show All
- Source
- Cite
- Save
Citations (126)
Addition of Bevacizumab to Standard Radiation Therapy and Daily Temozolomide Is Associated With Minimal Toxicity in Newly Diagnosed Glioblastoma Multiforme

2012 International Journal of Radiation Oncology Biology Physics
Show All
- Source
- Cite
- Save
Citations (67)
The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide and Irinotecan for Newly Diagnosed Glioblastoma

2011 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (126)
Venous thromboembolic complications in patients with malignant glioma treated on a bevacizumab clinical trial.

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Bevacizumab, temozolomide, and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly-diagnosed glioblastoma multiforme (GBM).

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (8)
Upfront bevacizumab with temozolomide or with temozolomide and irinotecan for unresectable or multifocal glioblastoma.

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (7)
Bevacizumab (BEV) in combination with temozolomide (TMZ) and radiation therapy (XRT) followed by BEV, TMZ, and irinotecan for newly diagnosed glioblastoma multiforme (GBM).

2010 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (9)
Temozolomide (TMZ) and bevacizumab (BV) as initial treatment for unresectable or multifocal glioblastoma multiforme (GBM)

2009 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Safety and efficacy of the addition of bevacizumab (BV) to temozolomide (TMZ) and radiation therapy (RT) followed by BV, TMZ, and irinotecan (CPT-11) for newly diagnosed glioblastoma multiforme (GBM)

2009 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (7)